| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125343 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/03/2003 | US20030125339 Substituted alkylamine derivatives and methods of use |
| 07/03/2003 | US20030125338 Compounds, compositions and methods for modulating beta-amyloid production |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | US20030125309 Cyclic ether vitamin D3 compounds, 1alpha(OH) 3-epi- vitamin D3 compounds and uses thereof |
| 07/03/2003 | US20030125308 Antipruritic agents for external use |
| 07/03/2003 | US20030125307 Transdermally administering a preparation containing only acetylsalicylic acid as an active ingredient; bronchial asthma, allergic rhinitis, atopic dermatitis; eczema, lichen Vidal; insect stings; pruritis; side effect reduction |
| 07/03/2003 | US20030125299 Method for treating or preventing inflammatory diseases |
| 07/03/2003 | US20030125294 Selective toxin expression in angiogenic endothelial cells |
| 07/03/2003 | US20030125264 Therapeutic flavonoid selected from flavones, flavonols, flavanones, isoflavanones, such as naringin, hesperidin, silybin, daidzin, genistin, genistein, quercetin and rutin. |
| 07/03/2003 | US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030124534 Measuring expression of nucleotide sequences in cells |
| 07/03/2003 | US20030124205 Topical cosmetic composition having a natural plant active ingredient and method of using same |
| 07/03/2003 | US20030124190 Methods and compositions for treating pain of the mucous membrane |
| 07/03/2003 | US20030124161 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/03/2003 | US20030124160 Targeted drug delivery |
| 07/03/2003 | US20030124159 Enhancing epidermal barrier development in skin |
| 07/03/2003 | US20030124150 Kit for reducing aching |
| 07/03/2003 | US20030124129 Angiopoietin-2 specific binding agents |
| 07/03/2003 | US20030124123 Also an IL-12 anti-idiotype antibody to the antibody |
| 07/03/2003 | US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 07/03/2003 | US20030124110 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 07/03/2003 | US20030124100 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 07/03/2003 | US20030124086 Polymer conjugates of opioid antagonists |
| 07/03/2003 | US20030124079 Novel cationic associative polyurethanes and their use as thickeners |
| 07/03/2003 | US20030124075 Use of a composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/03/2003 | US20030124071 Containing 1,1,1-tris(2-methyl-4-hydroxy-5-tert-butylphenyl) butane |
| 07/03/2003 | CA2849201A1 Adipose-derived cell processing unit |
| 07/03/2003 | CA2471087A1 Pyrazolyl-substituted triazoloquinoxalines |
| 07/03/2003 | CA2471085A1 Aroyl pyridinones |
| 07/03/2003 | CA2471083A1 Benzhydryl derivatives |
| 07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | CA2470900A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/03/2003 | CA2470603A1 Methods for the treatment of peripheral neural and vascular ailments |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | CA2470364A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases |
| 07/03/2003 | CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration |
| 07/03/2003 | CA2469370A1 Adipose-derived cell processing unit |
| 07/03/2003 | CA2468083A1 Use of heterocyclic carboxamides to treat anemia |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323713A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 07/02/2003 | EP1323413A1 Light screening composition comprising a 1,3,5-triazine derivative, a dibenzoylmethane derivative and an amino substituted 2-hydroxybenzophenone derivative |
| 07/02/2003 | EP1323412A1 Light screening composition comprising a dibenzoylmethane type screening agent and an amino substituted 2-hydroxybenzophenone derivative |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322663A1 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5- g(a)-androst-1-en-3-one and a process for preparing it |
| 07/02/2003 | EP1322645A2 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof |
| 07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
| 07/02/2003 | EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 07/02/2003 | EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/02/2003 | EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 07/02/2003 | EP1322310A1 Alpha v integrin receptor antagonists |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 07/02/2003 | EP1322162A1 Disinfectant agent |
| 07/02/2003 | EP1224180B1 Substituted azoles |
| 07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1210346B1 New active marine alkaloids |
| 07/02/2003 | EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 07/02/2003 | EP1150666A4 Stimulating neutrophil function to treat inflammatory bowel disease |
| 07/02/2003 | EP0900211B1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
| 07/02/2003 | EP0626864B1 Topical composition containing hyaluronic acid and nsaids |
| 07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
| 07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 07/02/2003 | CN1427714A External skin preparations for suppressing sebum secretion |
| 07/02/2003 | CN1427707A External preparation for skin and beautifying agents |
| 07/02/2003 | CN1427012A Recombination human thymus peptide beta 4Y and its preparation method and use |
| 07/02/2003 | CN1426815A Film forming liquid composition |
| 07/02/2003 | CN1426809A Extenal use ointment for restoring period of knocks and falls |
| 07/02/2003 | CN1426803A Preparation for eliminating skin hyperplasia |
| 07/02/2003 | CN1426793A Formulation of skin protecting and health care capsule |
| 07/02/2003 | CN1426786A Ointment made of Chinese medicinal herbs for treating bedsore difficult to cure |
| 07/02/2003 | CN1113057C Quinoline derivatives |
| 07/02/2003 | CN1112917C Skin whitener composition containing mercaptodextran |
| 07/02/2003 | CN1112916C Composition containing free kind sphingol alkali and ceramide and its usage |
| 07/02/2003 | CN1112911C Composition for making-up and/or skin and use thereof |
| 07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586472 Treatment of rosacea using lipoic acid |
| 07/01/2003 | US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide |
| 07/01/2003 | US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea |
| 07/01/2003 | US6586432 Neurokinin-1 receptor antagonists |
| 07/01/2003 | US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/01/2003 | US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 07/01/2003 | US6586424 Anticancer agents; anticholesterol agents |
| 07/01/2003 | US6586423 Tyrosine kinase inhibitors |
| 07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
| 07/01/2003 | US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 07/01/2003 | US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 07/01/2003 | US6585963 Nail compositions and methods of administering same |
| 07/01/2003 | CA2166243C Apoptosis-modulating composition containing a factor modifying intracellular methional and malondialdehyde rates |
| 06/26/2003 | WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene |
| 06/26/2003 | WO2003052048A2 Nucleic acid-associated proteins |
| 06/26/2003 | WO2003051979A2 Compositions and methods for high sorption of skin materials and delivery of sulfur |